James Maitland is a prominent authority in the intersection of healthcare economics and regulatory policy, known for his rigorous analysis of how financial incentives shape patient care. With a career spanning decades in health insurance oversight, Maitland has become a leading voice in deciphering the complexities of Medicare Advantage and the digital frameworks that manage billions of dollars in federal reimbursements. His expertise is particularly vital as the government intensifies its scrutiny of billing practices among the nation’s largest insurers, seeking to ensure that the privatized Medicare program remains both sustainable and honest for the millions of seniors who rely on it.
In this conversation, we delve into the mechanics of medical upcoding and the recent federal audits that have placed industry giants in the crosshairs for overcollecting hundreds of millions of dollars. We examine the specific documentation failures involving high-risk conditions like stroke and sepsis, the systemic incentives that encourage insurers to exaggerate patient illness, and the defiant response from major carriers who challenge the government’s auditing techniques. Maitland also sheds light on the broader implications for smaller regional insurers and provides a detailed outlook on the future of billing integrity within the Medicare Advantage framework through the end of this decade.
How does the specific process of submitting diagnosis codes for acute conditions like stroke or sepsis lead to such substantial financial overpayments within the Medicare Advantage program?
The financial architecture of Medicare Advantage is built on a “per member, per month” payment model, which is fundamentally designed to be risk-adjusted so that insurers are compensated more for taking on sicker patients. When an insurer submits a diagnosis code for a severe condition like an acute stroke or sepsis, it triggers a significant upward adjustment in that member’s risk score, reflecting the anticipated high cost of their care. However, the recent HHS Office of Inspector General audits revealed a staggering disconnect where Humana and UnitedHealthcare allegedly overcharged the government nearly $180 million across just two years by submitting codes that were not supported by actual medical records. In many cases, these insurers were recording the most severe possible version of a condition or claiming for illnesses that a patient had long since recovered from, essentially creating a “phantom” health burden that exists only on paper. This practice, known as upcoding, turns a standard medical encounter into a high-value billing event, with HumanaChoice and UnitedHealthcare of Wisconsin generating $131 million and $47 million in extra reimbursements respectively through these unsupported claims.
The audit focused on “high-risk” diagnosis groups to identify these discrepancies; what do the specific numbers revealed in the samples tell us about the reliability of the data currently being used to determine health status?
The data reveals a systemic failure in documentation that is frankly alarming when you look at the sheer volume of unsupported claims within the audited samples. For HumanaChoice, the federal watchdog examined 220 “enrollee-years” and found that 178 of them—over 80%—lacked the necessary medical documentation to justify the high-risk diagnosis codes submitted. UnitedHealthcare of Wisconsin showed a similar pattern, where 183 out of 250 sampled enrollee-years were found to be improperly coded, leading to an estimated $722,000 in direct overpayments for just those specific cases. When these figures are extrapolated across the entire contracts for these insurers, which cover nearly 15 million seniors, the financial implications are massive, suggesting that the “risk adjustment” intended to level the playing field is instead being used as a lever for profit. It creates a sensory image of a vast digital filing cabinet where the labels on the outside—sepsis, embolism, heart attack—simply do not match the clinical reality of the folders inside, yet the government continues to pay out based on those misleading labels.
In light of the Senate investigation finding that some insurers employ an “army of coders,” how do these corporate strategies specifically incentivize external providers to capture more aggressive diagnoses?
The corporate strategy involves a highly sophisticated infrastructure designed to maximize risk scores by leaving no potential diagnosis uncaptured, often putting immense pressure on the clinical workflow. These “armies of coders” are tasked with scouring every inch of a patient’s medical history to find any mention of a chronic or acute condition that can be translated into a higher payment tier. Furthermore, some insurers have been known to offer financial incentives or specialized assessment tools to external healthcare providers, encouraging them to be more “thorough”—which often translates to being more aggressive—in identifying high-risk conditions. This creates a culture where the focus shifts from clinical outcomes to administrative optimization, as providers are nudged to record every possible ailment during a visit to ensure the insurer hits their revenue targets. It is a calculated, data-driven approach that treats a patient’s health profile as a financial asset to be optimized rather than a medical history to be managed.
Why have Humana and UnitedHealthcare taken such a defiant stance against these audit findings, and what does their refusal to return the funds suggest about the current regulatory environment?
The defiance we are seeing stems from a fundamental disagreement over how the government validates health data, with both Humana and UnitedHealthcare labeling the HHS OIG’s methodology as “flawed” and “skewed” toward finding overpayments. They argue that the audit process does not reflect the complexities of modern medical coding and that they have no legal obligation to return the hundreds of millions of dollars identified until a “final determination” is reached. This standoff highlights a significant gap in the current regulatory environment where the enforcement agency can identify clear discrepancies, yet the insurers can continue to hold onto the funds while challenging the very rules of the game. It is a high-stakes clash of titans; the insurers are fighting to preserve their profit margins and a billing system that favors their bottom line, while the government is struggling to modernize oversight in a way that can actually keep pace with private industry’s aggressive tactics. This friction suggests that the battle for Medicare Advantage integrity is moving into a more litigious phase where technical arguments about “methodology” are used to shield companies from the consequences of their billing errors.
While the focus is often on the giants like UnitedHealthcare, how significant is the issue of improper coding among smaller, regional insurers who provide coverage for seniors?
While the dollar amounts might be smaller in absolute terms, the audits of regional plans show that the practice of upcoding is pervasive across the entire industry, regardless of the company’s size. For example, recent audits of Blue Cross and Blue Shield of Alabama, Gateway Health Plan, and Priority Health revealed overpayments ranging from $4.3 million to $7 million over a two-year period due to improper high-risk diagnosis submissions. This indicates that the “playbook” for maximizing Medicare Advantage revenue is well-understood and utilized by plans of all scales, suggesting a standardized industry-wide approach to risk score manipulation. For these smaller insurers, a $7 million overpayment is a significant portion of their revenue, proving that the incentive to exaggerate patient health needs is a universal temptation in a system that rewards sickness over wellness. It demonstrates that the HHS OIG has a massive task ahead, as they must police not just the industry leaders but a fragmented landscape of regional providers who are all operating under the same flawed incentive structure.
What is your forecast for the future of Medicare Advantage billing integrity and the federal government’s ability to curb upcoding through 2028?
I forecast a period of intense regulatory tightening and technological modernization from 2026 to 2028, as the CMS implements more aggressive policies to ensure that every diagnosis code is tied directly to a verifiable medical encounter. We are going to see a shift where the government moves away from simple retrospective audits toward real-time data validation, utilizing more advanced algorithms to flag “implausible” or unsupported high-risk codes before the payments are even processed. The pushback from insurers will likely lead to a series of high-profile legal battles, but the sheer weight of the $180 million in overcharges recently uncovered will provide the political capital needed for more stringent oversight. By 2028, I expect the “army of coders” model to be under such heavy fire that insurers will be forced to pivot toward more transparent documentation practices, or face escalating penalties that could finally outweigh the financial benefits of upcoding. The era of “gaming the system” through undocumented diagnoses is coming to a close, as the digital trail left by these companies makes it increasingly impossible to hide the gap between a member’s actual health and their billed risk score.
